Scholarlink

<p>Immunotherapy has demonstrated activity in metastatic penile cancer. Shan and colleagues report encouraging safety, efficacy, and tolerability of perioperative chemoimmunotherapy in advanced disease. While these results are promising, they underscore the urgent need for randomized trials to define the role and timing of immunotherapy in this rare and lethal disease.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Front-line chemo-immunotherapy for advanced penile cancer: ready for prime time?

  • 期刊论文

  • 发表日期：

    2026年6月23日

查看全文
  • Zachariah Thomas,
  • Curtis A. Pettaway,
  • Omar Alhalabi,
  • Matthew T. Campbell,
  • Andrew C. Johns

摘要

Immunotherapy has demonstrated activity in metastatic penile cancer. Shan and colleagues report encouraging safety, efficacy, and tolerability of perioperative chemoimmunotherapy in advanced disease. While these results are promising, they underscore the urgent need for randomized trials to define the role and timing of immunotherapy in this rare and lethal disease.